Chunmei Xiao1*, Yong Kang1 and Yong-Chang Zhuang2
Parkinson’s disease (PD) is a neurodegenerative disorder of the basal ganglia that affects approximately 1.5% of adults over the age of 65 . This proportion is higher in PD, where approximately 40% of patients use some form of alternative therapy for treatment of PD symptoms